首页 正文

Chemotherapy alone for localized diffuse large B-cell lymphoma

{{output}}
Approximately 25% to 30% of patients with diffuse large B-cell lymphoma (DLBCL) present with limited-stage disease, typically defined as those with nonbulky (<10 cm) Ann Arbor stage I or II disease, without B-symptoms and with sites that can be encompassed wit... ...